1. Home
  2. ASYS vs CRBP Comparison

ASYS vs CRBP Comparison

Compare ASYS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$11.52

Market Cap

164.5M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.52

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
CRBP
Founded
1981
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
170.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASYS
CRBP
Price
$11.52
$7.52
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$50.29
AVG Volume (30 Days)
626.1K
153.3K
Earning Date
02-05-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$73,952,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
$220.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$4.64
52 Week High
$18.59
$20.56

Technical Indicators

Market Signals
Indicator
ASYS
CRBP
Relative Strength Index (RSI) 39.89 38.06
Support Level $10.88 $7.26
Resistance Level $13.26 $7.97
Average True Range (ATR) 1.40 0.54
MACD -0.73 -0.04
Stochastic Oscillator 16.43 10.82

Price Performance

Historical Comparison
ASYS
CRBP

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: